Mylan CEO Heather Bresch to retire after deal to merge with Pfizer’s Upjohn closes
By Mylan N.V. said that in connection with the deal to merge with Pfizer Inc.’s Upjohn business announced Monday, Chief Executive Heather Bresch will retire, after more than 8 years in the role and 28 years at the company. The retirement will be effective when the deal closes, which is expected in mid-2020.
Name: Heather Bresch
Country: Netherlands
Company: Mylan N.V.
Branch: Pharma
Position: CEO
Reason: Retired
Announcement Date: July 28, 2019, 10:00pm
Resignation Date: July 28, 2019, 10:00pm